Description

Nuvation Bio, Inc. operates as a biopharmaceutical firm dedicated to addressing critical unmet needs within oncology. It does so by pioneering distinctive and innovative therapeutic candidates. Its exclusive pipeline features six cutting-edge cancer treatment products, each employing a unique mechanism of action and specifically designed to combat some of the most challenging types of malignancies. David Hung established the company on March 20, 2018, and its headquarters are situated in New York, NY.